Home
Company Overview Our Journey Founder’s Message Leadership Team Vision & Mission Core Values Growth Timeline Why Choose Amro
By Category Analgesics Anti-Allergic Gastro & Antacids CNS Range Nutraceuticals Pediatric Range Antibiotics Ayurvedic Range By Dosage Form Tablets Capsules Syrups Drops Softgels Powders Oils Other Options ⭐ Featured Products πŸ”₯ New Launches πŸ“„ Product Catalogue PDF
Franchise Opportunities Distributorship Direct Orders Business Partnership Marketing Support
Quality Commitment Manufacturing Standards Product Research Quality Control Compliance & Ethics
Careers Contact Us
Home > Products > Cardiovascular > Amros AT

Amros AT

Amlodipine Besylate IP (equivalent to Amlodipine) + Atenolol IP

Amro Pharmaceuticals Amros AT packaging - Cardiovascular formulation

Product Inquiry

Interested in commercial distribution, PCD franchise, or wholesale orders for Amros AT?

Chat on WhatsApp

Formulation Composition

Active Ingredients & Strength
Amlodipine Besylate IP (equivalent to Amlodipine)5 mg
Atenolol IP10 mg
ExcipientsQ.S.
IP – Indian Pharmacopoeia  |  USP – United States Pharmacopeia  |  BP – British Pharmacopoeia  |  Q.S. – Quantum Sufficit (sufficient quantity). All ingredients meet pharmaceutical-grade purity standards.

Therapeutic Indications

  • Essential hypertension and blood pressure management
  • Angina pectoris and chest pain relief
  • Prevention of cardiovascular events (MI, stroke)
  • Heart rate control in certain arrhythmias
  • Combined antihypertensive therapy

Indications listed are general to the category. Specific use should be as per physician's clinical assessment.

Key Clinical Benefits

Clinically Formulated: Developed to meet high pharmaceutical quality and efficacy standards.

Packaging Configuration

Pack Size
20strips
Carton Config
1*1*20
Pack Type
PVC Blister with Foil
Storage
Cool Dry Place

All packaging conforms to Schedule M GMP standards of the Drugs & Cosmetics Act, 1940.

Safety & Precautions

  • Do not discontinue Beta-blockers abruptly β€” risk of rebound hypertension or angina.
  • Monitor blood pressure and heart rate at regular intervals during therapy.
  • Amlodipine may cause peripheral oedema (ankle swelling) β€” report to physician.
  • Not for use in patients with cardiogenic shock, second/third degree heart block, or decompensated heart failure.
  • Inform physician of all medications β€” multiple drug interactions possible with antihypertensives.
Schedule H Prescription Drug β€” Rx Only This medicine is sold by retail on the prescription of a Registered Medical Practitioner only. It is not to be recommended or used without a doctor's prescription. Not for Over-The-Counter (OTC) sale. As per the Drugs & Cosmetics Act, 1940, and Rules 1945.
This information is intended for qualified healthcare professionals and pharma trade partners. It is not a substitute for professional medical advice, diagnosis or treatment.

Frequently Asked Questions

Crawlable clinical insights about Amros AT for search queries and virtual healthcare guides.

What is the medical use of Amros AT?

Amros AT is a professionally formulated Tablet belonging to the Cardiovascular Care therapeutic class. It is primarily used for cardiac support and peripheral hypertension control, under strict guidelines of registered medical professionals.

What are the active ingredients in Amros AT?

The active composition of Amros AT consists of Amlodipine Besylate IP (equivalent to Amlodipine): 5 mg, Atenolol IP: 10 mg. This blend meets exact pharmacopoeia quality benchmarks (IP/BP/USP) to deliver optimal safety and performance.

What are the key storage conditions and precautions for Amros AT?

Store Amros AT in a cool, dry place away from direct sunlight. Maintain temperatures in accordance with GMP guidelines. Since this is a prescription medication, do not self-medicate and consult a licensed physician.